other · Healthcare · Biotechnology
ARQT
23.75-0.22 -0.92%Past year
Loading chart…
Loading financials…
Company snapshot
- Ticker
- ARQT
- Exchange
- NMS
- Sector
- Healthcare
- Industry
- Biotechnology
- Market cap
- $3.39B
- Employees
- 354
- Currency
- USD
- Website
- https://www.arcutis.com
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. The company's lead product is ZORYVE, a topical roflumilast cream for the treatment of plaque psoriasis and atopic dermatitis. It also develops ZORYVE foam seborrheic dermatitis, and scalp and body psoriasis treatment; ARQ-234, a fusion protein that is a potent and highly selective checkpoint agonist…
Latest coverage
No coverage yet — articles appear here automatically as press releases are published.
Related other stocks
Quotes & data
Follow Arcutis Biotherapeutics, Inc. (ARQT) across major market-data sources.